| 1 | age-related | 1,914 |
| 2 | neuromuscular | 1,629 |
| 3 | degenerative | 1,171 |
| 4 | hind | 266 |
| 5 | carrageenan-induced | 249 |
| 6 | restless | 233 |
| 7 | subfoveal | 211 |
| 8 | age-associated | 128 |
| 9 | calcific | 114 |
| 10 | cystoid | 74 |
| 11 | myxomatous | 62 |
| 12 | formalin-induced | 61 |
| 13 | aging-related | 49 |
| 14 | rocuronium-induced | 48 |
| 15 | polypoidal | 34 |
| 16 | extrafoveal | 24 |
| 17 | juxtafoveal | 16 |
| 18 | succinylcholine-induced | 15 |
| 19 | 2-gy | 14 |
| 20 | uveitic | 14 |
| 21 | vecuronium-induced | 14 |
| 22 | non-depolarizing | 13 |
| 23 | portal-drained | 13 |
| 24 | ionescu-shiley | 12 |
| 25 | serotonin-induced | 12 |
| 26 | alzheimer-type | 10 |
| 27 | carrageenin-induced | 10 |
| 28 | clinically-significant | 9 |
| 29 | prednisolone-induced | 8 |
| 30 | 1.8-gy | 6 |
| 31 | ad-type | 6 |
| 32 | interaction-induced | 6 |
| 33 | uncrossed | 6 |
| 34 | hyperpigmentary | 5 |
| 35 | middle-frequency | 5 |
| 36 | selenite-induced | 5 |
| 37 | walking-induced | 5 |
| 38 | 'age-related | 4 |
| 39 | alzheimer-like | 4 |
| 40 | mri-verified | 4 |
| 41 | myelodysplasia-related | 4 |
| 42 | transversalis | 4 |
| 43 | vagosympathetic | 4 |
| 44 | 16/6 | 3 |
| 45 | amlodipine-induced | 3 |
| 46 | anesthesiometer-induced | 3 |
| 47 | animals׳ | 3 |
| 48 | beta-zone | 3 |
| 49 | dextran-induced | 3 |
| 50 | donor-to-recipient | 3 |
| 51 | doppler-detected | 3 |
| 52 | electromyography-triggered | 3 |
| 53 | et-1-mediated | 3 |
| 54 | galactosemic | 3 |
| 55 | nerve-innervated | 3 |
| 56 | non-device-related | 3 |
| 57 | nonfibrillary | 3 |
| 58 | pcos-related | 3 |
| 59 | rvo-associated | 3 |
| 60 | suxamethonium-induced | 3 |
| 61 | tref | 3 |
| 62 | 2.4-gy | 2 |
| 63 | 4-miniplate-assisted | 2 |
| 64 | a-nociceptor | 2 |
| 65 | agerelated | 2 |
| 66 | atd-induced | 2 |
| 67 | bv-elicited | 2 |
| 68 | carr-induced | 2 |
| 69 | cisatracurium-induced | 2 |
| 70 | depression-induced | 2 |
| 71 | doppler-measured | 2 |
| 72 | ebnezar | 2 |
| 73 | endouterine | 2 |
| 74 | exsanguinate | 2 |
| 75 | fibrillin-rich | 2 |
| 76 | fruit-exposed | 2 |
| 77 | gestation-related | 2 |
| 78 | h2a.z-nucleosome | 2 |
| 79 | inactivity-induced | 2 |
| 80 | intra-limb | 2 |
| 81 | masturbatory | 2 |
| 82 | mvf-induced | 2 |
| 83 | non-instructed | 2 |
| 84 | nuclear/cortico-nuclear | 2 |
| 85 | outcome-triggered | 2 |
| 86 | pgg-containing | 2 |
| 87 | pyoinflammatory | 2 |
| 88 | sclera-to-cornea | 2 |
| 89 | score-lower | 2 |
| 90 | severs | 2 |
| 91 | two-digit | 2 |
| 92 | u50,488 | 2 |
| 93 | unhomogeneous | 2 |
| 94 | water-accommodated | 2 |
| 95 | λ-carrageenan-induced | 2 |
| 96 | 180-200cgy | 1 |
| 97 | 19,250 | 1 |
| 98 | 2.67-gy | 1 |
| 99 | 271.36 | 1 |
| 100 | 3,072 | 1 |
| 101 | 4-echo | 1 |
| 102 | 523,059 | 1 |
| 103 | 635/704 | 1 |
| 104 | a-cup | 1 |
| 105 | adca5-injected | 1 |
| 106 | addiction-associated | 1 |
| 107 | adematozna | 1 |
| 108 | alprazolam-related | 1 |
| 109 | assure-fluoride | 1 |
| 110 | aterogene | 1 |
| 111 | atracurium-induced | 1 |
| 112 | atypical/incomplete | 1 |
| 113 | bera-adrenergic | 1 |
| 114 | botox-injected | 1 |
| 115 | brvo-induced | 1 |
| 116 | bulbectomy-induced | 1 |
| 117 | carageenan-induced | 1 |
| 118 | carrageen-induced | 1 |
| 119 | central/ischemic | 1 |
| 120 | cfa-injected | 1 |
| 121 | chemosurgical | 1 |
| 122 | co/delta | 1 |
| 123 | cobi-free | 1 |
| 124 | collaterals-1,165 | 1 |
| 125 | crf5 | 1 |
| 126 | d-gal-induced | 1 |
| 127 | desinfect | 1 |
| 128 | eis-associated | 1 |
| 129 | ethyl-acetate/methanol | 1 |
| 130 | ethylacetate-soluble | 1 |
| 131 | fe-hydroxide | 1 |
| 132 | fracture/dislocated | 1 |
| 133 | gcamp3-functionalized | 1 |
| 134 | gonadothropin | 1 |
| 135 | gonadotrophin- | 1 |
| 136 | gray/33 | 1 |
| 137 | grk2/3-mediated | 1 |
| 138 | gy/4-5 | 1 |
| 139 | hdl2-hdl3 | 1 |
| 140 | hgcl₂-exposed | 1 |
| 141 | high-voltage/non-rapid | 1 |
| 142 | hypocalcemia-enhanced | 1 |
| 143 | hypoplasic | 1 |
| 144 | inoculation-induced | 1 |
| 145 | intergranular | 1 |
| 146 | letrozole-associated | 1 |
| 147 | low-failure | 1 |
| 148 | lower-polar | 1 |
| 149 | macrophage-enriched | 1 |
| 150 | melanoidin-digested | 1 |
| 151 | monolateral/bilateral | 1 |
| 152 | msa-p. | 1 |
| 153 | multiple-frame | 1 |
| 154 | neutral/basic | 1 |
| 155 | non-charcot | 1 |
| 156 | non-gloved | 1 |
| 157 | non-indoor-air-emitting | 1 |
| 158 | non-residual | 1 |
| 159 | non-salutary | 1 |
| 160 | nonarborizing | 1 |
| 161 | nonsoluble | 1 |
| 162 | omniax | 1 |
| 163 | ostim-filled | 1 |
| 164 | pain-provoked | 1 |
| 165 | pav-induced | 1 |
| 166 | pleuro- | 1 |
| 167 | primary/redo | 1 |
| 168 | publically-funded | 1 |
| 169 | puromycin-treated | 1 |
| 170 | radiotherapy-30 | 1 |
| 171 | rorqual | 1 |
| 172 | rtv-induced | 1 |
| 173 | saxton | 1 |
| 174 | semi-lipophilic | 1 |
| 175 | sfr-affected | 1 |
| 176 | solvent-partitioned | 1 |
| 177 | sublesional | 1 |
| 178 | subvalvular-sparing | 1 |
| 179 | systole-specific | 1 |
| 180 | thearubigin | 1 |
| 181 | tobacco-tar-stained | 1 |
| 182 | toreduce | 1 |
| 183 | triamcinolone-induced | 1 |
| 184 | true-sized | 1 |
| 185 | vecuroniuminduced | 1 |
| 186 | vision-impairing | 1 |
| 187 | λ-carageenan-induced | 1 |
| 1 | 'age-related | 4 |
| 2 | 1.8-gy | 6 |
| 3 | 16/6 | 3 |
| 4 | 180-200cgy | 1 |
| 5 | 19,250 | 1 |
| 6 | 2-gy | 14 |
| 7 | 2.4-gy | 2 |
| 8 | 2.67-gy | 1 |
| 9 | 271.36 | 1 |
| 10 | 3,072 | 1 |
| 11 | 4-echo | 1 |
| 12 | 4-miniplate-assisted | 2 |
| 13 | 523,059 | 1 |
| 14 | 635/704 | 1 |
| 15 | a-cup | 1 |
| 16 | a-nociceptor | 2 |
| 17 | ad-type | 6 |
| 18 | adca5-injected | 1 |
| 19 | addiction-associated | 1 |
| 20 | adematozna | 1 |
| 21 | age-associated | 128 |
| 22 | age-related | 1,914 |
| 23 | agerelated | 2 |
| 24 | aging-related | 49 |
| 25 | alprazolam-related | 1 |
| 26 | alzheimer-like | 4 |
| 27 | alzheimer-type | 10 |
| 28 | amlodipine-induced | 3 |
| 29 | anesthesiometer-induced | 3 |
| 30 | animals׳ | 3 |
| 31 | assure-fluoride | 1 |
| 32 | atd-induced | 2 |
| 33 | aterogene | 1 |
| 34 | atracurium-induced | 1 |
| 35 | atypical/incomplete | 1 |
| 36 | bera-adrenergic | 1 |
| 37 | beta-zone | 3 |
| 38 | botox-injected | 1 |
| 39 | brvo-induced | 1 |
| 40 | bulbectomy-induced | 1 |
| 41 | bv-elicited | 2 |
| 42 | calcific | 114 |
| 43 | carageenan-induced | 1 |
| 44 | carr-induced | 2 |
| 45 | carrageen-induced | 1 |
| 46 | carrageenan-induced | 249 |
| 47 | carrageenin-induced | 10 |
| 48 | central/ischemic | 1 |
| 49 | cfa-injected | 1 |
| 50 | chemosurgical | 1 |
| 51 | cisatracurium-induced | 2 |
| 52 | clinically-significant | 9 |
| 53 | co/delta | 1 |
| 54 | cobi-free | 1 |
| 55 | collaterals-1,165 | 1 |
| 56 | crf5 | 1 |
| 57 | cystoid | 74 |
| 58 | d-gal-induced | 1 |
| 59 | degenerative | 1,171 |
| 60 | depression-induced | 2 |
| 61 | desinfect | 1 |
| 62 | dextran-induced | 3 |
| 63 | donor-to-recipient | 3 |
| 64 | doppler-detected | 3 |
| 65 | doppler-measured | 2 |
| 66 | ebnezar | 2 |
| 67 | eis-associated | 1 |
| 68 | electromyography-triggered | 3 |
| 69 | endouterine | 2 |
| 70 | et-1-mediated | 3 |
| 71 | ethyl-acetate/methanol | 1 |
| 72 | ethylacetate-soluble | 1 |
| 73 | exsanguinate | 2 |
| 74 | extrafoveal | 24 |
| 75 | fe-hydroxide | 1 |
| 76 | fibrillin-rich | 2 |
| 77 | formalin-induced | 61 |
| 78 | fracture/dislocated | 1 |
| 79 | fruit-exposed | 2 |
| 80 | galactosemic | 3 |
| 81 | gcamp3-functionalized | 1 |
| 82 | gestation-related | 2 |
| 83 | gonadothropin | 1 |
| 84 | gonadotrophin- | 1 |
| 85 | gray/33 | 1 |
| 86 | grk2/3-mediated | 1 |
| 87 | gy/4-5 | 1 |
| 88 | h2a.z-nucleosome | 2 |
| 89 | hdl2-hdl3 | 1 |
| 90 | hgcl₂-exposed | 1 |
| 91 | high-voltage/non-rapid | 1 |
| 92 | hind | 266 |
| 93 | hyperpigmentary | 5 |
| 94 | hypocalcemia-enhanced | 1 |
| 95 | hypoplasic | 1 |
| 96 | inactivity-induced | 2 |
| 97 | inoculation-induced | 1 |
| 98 | interaction-induced | 6 |
| 99 | intergranular | 1 |
| 100 | intra-limb | 2 |
| 101 | ionescu-shiley | 12 |
| 102 | juxtafoveal | 16 |
| 103 | letrozole-associated | 1 |
| 104 | low-failure | 1 |
| 105 | lower-polar | 1 |
| 106 | macrophage-enriched | 1 |
| 107 | masturbatory | 2 |
| 108 | melanoidin-digested | 1 |
| 109 | middle-frequency | 5 |
| 110 | monolateral/bilateral | 1 |
| 111 | mri-verified | 4 |
| 112 | msa-p. | 1 |
| 113 | multiple-frame | 1 |
| 114 | mvf-induced | 2 |
| 115 | myelodysplasia-related | 4 |
| 116 | myxomatous | 62 |
| 117 | nerve-innervated | 3 |
| 118 | neuromuscular | 1,629 |
| 119 | neutral/basic | 1 |
| 120 | non-charcot | 1 |
| 121 | non-depolarizing | 13 |
| 122 | non-device-related | 3 |
| 123 | non-gloved | 1 |
| 124 | non-indoor-air-emitting | 1 |
| 125 | non-instructed | 2 |
| 126 | non-residual | 1 |
| 127 | non-salutary | 1 |
| 128 | nonarborizing | 1 |
| 129 | nonfibrillary | 3 |
| 130 | nonsoluble | 1 |
| 131 | nuclear/cortico-nuclear | 2 |
| 132 | omniax | 1 |
| 133 | ostim-filled | 1 |
| 134 | outcome-triggered | 2 |
| 135 | pain-provoked | 1 |
| 136 | pav-induced | 1 |
| 137 | pcos-related | 3 |
| 138 | pgg-containing | 2 |
| 139 | pleuro- | 1 |
| 140 | polypoidal | 34 |
| 141 | portal-drained | 13 |
| 142 | prednisolone-induced | 8 |
| 143 | primary/redo | 1 |
| 144 | publically-funded | 1 |
| 145 | puromycin-treated | 1 |
| 146 | pyoinflammatory | 2 |
| 147 | radiotherapy-30 | 1 |
| 148 | restless | 233 |
| 149 | rocuronium-induced | 48 |
| 150 | rorqual | 1 |
| 151 | rtv-induced | 1 |
| 152 | rvo-associated | 3 |
| 153 | saxton | 1 |
| 154 | sclera-to-cornea | 2 |
| 155 | score-lower | 2 |
| 156 | selenite-induced | 5 |
| 157 | semi-lipophilic | 1 |
| 158 | serotonin-induced | 12 |
| 159 | severs | 2 |
| 160 | sfr-affected | 1 |
| 161 | solvent-partitioned | 1 |
| 162 | subfoveal | 211 |
| 163 | sublesional | 1 |
| 164 | subvalvular-sparing | 1 |
| 165 | succinylcholine-induced | 15 |
| 166 | suxamethonium-induced | 3 |
| 167 | systole-specific | 1 |
| 168 | thearubigin | 1 |
| 169 | tobacco-tar-stained | 1 |
| 170 | toreduce | 1 |
| 171 | transversalis | 4 |
| 172 | tref | 3 |
| 173 | triamcinolone-induced | 1 |
| 174 | true-sized | 1 |
| 175 | two-digit | 2 |
| 176 | u50,488 | 2 |
| 177 | uncrossed | 6 |
| 178 | unhomogeneous | 2 |
| 179 | uveitic | 14 |
| 180 | vagosympathetic | 4 |
| 181 | vecuronium-induced | 14 |
| 182 | vecuroniuminduced | 1 |
| 183 | vision-impairing | 1 |
| 184 | walking-induced | 5 |
| 185 | water-accommodated | 2 |
| 186 | λ-carageenan-induced | 1 |
| 187 | λ-carrageenan-induced | 2 |
| 1 | gonadotrophin- | 1 |
| 2 | pleuro- | 1 |
| 3 | msa-p. | 1 |
| 4 | radiotherapy-30 | 1 |
| 5 | 19,250 | 1 |
| 6 | 3,072 | 1 |
| 7 | gray/33 | 1 |
| 8 | hdl2-hdl3 | 1 |
| 9 | 635/704 | 1 |
| 10 | gy/4-5 | 1 |
| 11 | collaterals-1,165 | 1 |
| 12 | crf5 | 1 |
| 13 | 16/6 | 3 |
| 14 | 271.36 | 1 |
| 15 | u50,488 | 2 |
| 16 | 523,059 | 1 |
| 17 | sclera-to-cornea | 2 |
| 18 | adematozna | 1 |
| 19 | co/delta | 1 |
| 20 | intra-limb | 2 |
| 21 | systole-specific | 1 |
| 22 | calcific | 114 |
| 23 | bera-adrenergic | 1 |
| 24 | semi-lipophilic | 1 |
| 25 | central/ischemic | 1 |
| 26 | galactosemic | 3 |
| 27 | neutral/basic | 1 |
| 28 | hypoplasic | 1 |
| 29 | vagosympathetic | 4 |
| 30 | uveitic | 14 |
| 31 | hypocalcemia-enhanced | 1 |
| 32 | atd-induced | 2 |
| 33 | succinylcholine-induced | 15 |
| 34 | amlodipine-induced | 3 |
| 35 | triamcinolone-induced | 1 |
| 36 | prednisolone-induced | 8 |
| 37 | selenite-induced | 5 |
| 38 | mvf-induced | 2 |
| 39 | walking-induced | 5 |
| 40 | d-gal-induced | 1 |
| 41 | suxamethonium-induced | 3 |
| 42 | vecuronium-induced | 14 |
| 43 | rocuronium-induced | 48 |
| 44 | atracurium-induced | 1 |
| 45 | cisatracurium-induced | 2 |
| 46 | carageenan-induced | 1 |
| 47 | λ-carageenan-induced | 1 |
| 48 | carrageenan-induced | 249 |
| 49 | λ-carrageenan-induced | 2 |
| 50 | dextran-induced | 3 |
| 51 | carrageen-induced | 1 |
| 52 | formalin-induced | 61 |
| 53 | carrageenin-induced | 10 |
| 54 | serotonin-induced | 12 |
| 55 | depression-induced | 2 |
| 56 | inoculation-induced | 1 |
| 57 | interaction-induced | 6 |
| 58 | brvo-induced | 1 |
| 59 | anesthesiometer-induced | 3 |
| 60 | carr-induced | 2 |
| 61 | pav-induced | 1 |
| 62 | rtv-induced | 1 |
| 63 | bulbectomy-induced | 1 |
| 64 | inactivity-induced | 2 |
| 65 | vecuroniuminduced | 1 |
| 66 | publically-funded | 1 |
| 67 | macrophage-enriched | 1 |
| 68 | mri-verified | 4 |
| 69 | pain-provoked | 1 |
| 70 | ostim-filled | 1 |
| 71 | portal-drained | 13 |
| 72 | tobacco-tar-stained | 1 |
| 73 | solvent-partitioned | 1 |
| 74 | outcome-triggered | 2 |
| 75 | electromyography-triggered | 3 |
| 76 | doppler-measured | 2 |
| 77 | fruit-exposed | 2 |
| 78 | hgcl₂-exposed | 1 |
| 79 | uncrossed | 6 |
| 80 | fracture/dislocated | 1 |
| 81 | water-accommodated | 2 |
| 82 | puromycin-treated | 1 |
| 83 | age-associated | 128 |
| 84 | letrozole-associated | 1 |
| 85 | addiction-associated | 1 |
| 86 | rvo-associated | 3 |
| 87 | eis-associated | 1 |
| 88 | et-1-mediated | 3 |
| 89 | grk2/3-mediated | 1 |
| 90 | myelodysplasia-related | 4 |
| 91 | non-device-related | 3 |
| 92 | age-related | 1,914 |
| 93 | 'age-related | 4 |
| 94 | aging-related | 49 |
| 95 | alprazolam-related | 1 |
| 96 | gestation-related | 2 |
| 97 | pcos-related | 3 |
| 98 | agerelated | 2 |
| 99 | nerve-innervated | 3 |
| 100 | sfr-affected | 1 |
| 101 | adca5-injected | 1 |
| 102 | cfa-injected | 1 |
| 103 | botox-injected | 1 |
| 104 | doppler-detected | 3 |
| 105 | non-instructed | 2 |
| 106 | bv-elicited | 2 |
| 107 | melanoidin-digested | 1 |
| 108 | 4-miniplate-assisted | 2 |
| 109 | non-gloved | 1 |
| 110 | gcamp3-functionalized | 1 |
| 111 | true-sized | 1 |
| 112 | cystoid | 74 |
| 113 | high-voltage/non-rapid | 1 |
| 114 | hind | 266 |
| 115 | toreduce | 1 |
| 116 | assure-fluoride | 1 |
| 117 | fe-hydroxide | 1 |
| 118 | cobi-free | 1 |
| 119 | alzheimer-like | 4 |
| 120 | ethylacetate-soluble | 1 |
| 121 | nonsoluble | 1 |
| 122 | multiple-frame | 1 |
| 123 | h2a.z-nucleosome | 2 |
| 124 | aterogene | 1 |
| 125 | endouterine | 2 |
| 126 | beta-zone | 3 |
| 127 | ad-type | 6 |
| 128 | alzheimer-type | 10 |
| 129 | low-failure | 1 |
| 130 | exsanguinate | 2 |
| 131 | atypical/incomplete | 1 |
| 132 | degenerative | 1,171 |
| 133 | tref | 3 |
| 134 | pgg-containing | 2 |
| 135 | subvalvular-sparing | 1 |
| 136 | vision-impairing | 1 |
| 137 | non-indoor-air-emitting | 1 |
| 138 | non-depolarizing | 13 |
| 139 | nonarborizing | 1 |
| 140 | fibrillin-rich | 2 |
| 141 | chemosurgical | 1 |
| 142 | polypoidal | 34 |
| 143 | extrafoveal | 24 |
| 144 | juxtafoveal | 16 |
| 145 | subfoveal | 211 |
| 146 | sublesional | 1 |
| 147 | monolateral/bilateral | 1 |
| 148 | non-residual | 1 |
| 149 | rorqual | 1 |
| 150 | ethyl-acetate/methanol | 1 |
| 151 | thearubigin | 1 |
| 152 | gonadothropin | 1 |
| 153 | saxton | 1 |
| 154 | primary/redo | 1 |
| 155 | 4-echo | 1 |
| 156 | a-cup | 1 |
| 157 | nuclear/cortico-nuclear | 2 |
| 158 | lower-polar | 1 |
| 159 | neuromuscular | 1,629 |
| 160 | intergranular | 1 |
| 161 | ebnezar | 2 |
| 162 | score-lower | 2 |
| 163 | a-nociceptor | 2 |
| 164 | transversalis | 4 |
| 165 | severs | 2 |
| 166 | restless | 233 |
| 167 | unhomogeneous | 2 |
| 168 | myxomatous | 62 |
| 169 | desinfect | 1 |
| 170 | two-digit | 2 |
| 171 | clinically-significant | 9 |
| 172 | donor-to-recipient | 3 |
| 173 | non-charcot | 1 |
| 174 | omniax | 1 |
| 175 | middle-frequency | 5 |
| 176 | ionescu-shiley | 12 |
| 177 | 2-gy | 14 |
| 178 | 2.4-gy | 2 |
| 179 | 2.67-gy | 1 |
| 180 | 1.8-gy | 6 |
| 181 | 180-200cgy | 1 |
| 182 | nonfibrillary | 3 |
| 183 | hyperpigmentary | 5 |
| 184 | non-salutary | 1 |
| 185 | masturbatory | 2 |
| 186 | pyoinflammatory | 2 |
| 187 | animals׳ | 3 |